🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the safety of a new biologic drug, RBX2660 (microbio...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2013-08
Trial ID
NCT01925417
Treatments Being Tested
The purpose of the study is to determine if fecal microbiota transplant (FM...
Status
Completed
Location
University of Alberta Hospital
Start Date
2016-04-12
Trial ID
NCT03439982
Treatments Being Tested
This study will evaluate efficacy and safety information about RBX2660 for ...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02589847
Treatments Being Tested
This trial will be initiated to explore whether RBX2660 (REBYOTA®) could be...
Status
Completed
Location
Ferring Investigational Site
Start Date
2023-04-21
Trial ID
NCT05831189
Treatments Being Tested
This is a prospective, multicenter, randomized, double-blinded, placebo-con...
Status
Completed
Location
Athens
Start Date
2017-07-31
Trial ID
NCT03244644
Treatments Being Tested
This is a prospective, multicenter, open-label Phase 3 study of a microbiot...
Status
Completed
Location
Phoenix
Start Date
2019-07-30
Trial ID
NCT03931941
Treatments Being Tested
This is the first prospective, multi-center, double-blinded, randomized con...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2014-12
Trial ID
NCT02299570
Treatments Being Tested